Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study.

Standard

Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study. / Lewczuk, P; Kamrowski-Kruck, H; Peters, O; Heuser, I; Jessen, F; Popp, J; Bürger, K; Hampel, H; Frölich, L; Wolf, S; Prinz, B; Jahn, Holger; Luckhaus, Ch; Perneczky, R; Hüll, M; Schröder, J; Kessler, H; Pantel, J; Gertz, H-J; Klafki, H-W; Kölsch, H; Reulbach, U; Esselmann, H; Maler, J M; Bibl, M; Kornhuber, J; Wiltfang, J.

In: MOL PSYCHIATR, 2008.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Lewczuk, P, Kamrowski-Kruck, H, Peters, O, Heuser, I, Jessen, F, Popp, J, Bürger, K, Hampel, H, Frölich, L, Wolf, S, Prinz, B, Jahn, H, Luckhaus, C, Perneczky, R, Hüll, M, Schröder, J, Kessler, H, Pantel, J, Gertz, H-J, Klafki, H-W, Kölsch, H, Reulbach, U, Esselmann, H, Maler, JM, Bibl, M, Kornhuber, J & Wiltfang, J 2008, 'Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study.', MOL PSYCHIATR. <http://www.ncbi.nlm.nih.gov/pubmed/18663368?dopt=Citation>

APA

Lewczuk, P., Kamrowski-Kruck, H., Peters, O., Heuser, I., Jessen, F., Popp, J., Bürger, K., Hampel, H., Frölich, L., Wolf, S., Prinz, B., Jahn, H., Luckhaus, C., Perneczky, R., Hüll, M., Schröder, J., Kessler, H., Pantel, J., Gertz, H-J., ... Wiltfang, J. (2008). Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study. MOL PSYCHIATR. http://www.ncbi.nlm.nih.gov/pubmed/18663368?dopt=Citation

Vancouver

Bibtex

@article{e892fc6de51344fe8327ea7a902fa110,
title = "Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study.",
abstract = "In this report, we present the results of a multicenter study to test analytic and diagnostic performance of soluble forms of amyloid precursor proteins alpha and beta (sAPPalpha and sAPPbeta) in the cerebrospinal fluid (CSF) of patients with different forms of dementing conditions. CSF samples were collected from 188 patients with early dementia (mini-mental state examination>/=20 in majority of cases) and mild cognitive impairment (MCI) in 12 gerontopsychiatric centers, and the clinical diagnoses were supported by neurochemical dementia diagnostic (NDD) tools: CSF amyloidbeta peptides, Tau and phospho-Tau. sAPPalpha and sAPPbeta were measured with multiplexing method based on electrochemiluminescence. sAPPalpha and sAPPbeta CSF concentrations correlated with each other with very high correlation ratio (R=0.96, P",
author = "P Lewczuk and H Kamrowski-Kruck and O Peters and I Heuser and F Jessen and J Popp and K B{\"u}rger and H Hampel and L Fr{\"o}lich and S Wolf and B Prinz and Holger Jahn and Ch Luckhaus and R Perneczky and M H{\"u}ll and J Schr{\"o}der and H Kessler and J Pantel and H-J Gertz and H-W Klafki and H K{\"o}lsch and U Reulbach and H Esselmann and Maler, {J M} and M Bibl and J Kornhuber and J Wiltfang",
year = "2008",
language = "Deutsch",
journal = "MOL PSYCHIATR",
issn = "1359-4184",
publisher = "NATURE PUBLISHING GROUP",

}

RIS

TY - JOUR

T1 - Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study.

AU - Lewczuk, P

AU - Kamrowski-Kruck, H

AU - Peters, O

AU - Heuser, I

AU - Jessen, F

AU - Popp, J

AU - Bürger, K

AU - Hampel, H

AU - Frölich, L

AU - Wolf, S

AU - Prinz, B

AU - Jahn, Holger

AU - Luckhaus, Ch

AU - Perneczky, R

AU - Hüll, M

AU - Schröder, J

AU - Kessler, H

AU - Pantel, J

AU - Gertz, H-J

AU - Klafki, H-W

AU - Kölsch, H

AU - Reulbach, U

AU - Esselmann, H

AU - Maler, J M

AU - Bibl, M

AU - Kornhuber, J

AU - Wiltfang, J

PY - 2008

Y1 - 2008

N2 - In this report, we present the results of a multicenter study to test analytic and diagnostic performance of soluble forms of amyloid precursor proteins alpha and beta (sAPPalpha and sAPPbeta) in the cerebrospinal fluid (CSF) of patients with different forms of dementing conditions. CSF samples were collected from 188 patients with early dementia (mini-mental state examination>/=20 in majority of cases) and mild cognitive impairment (MCI) in 12 gerontopsychiatric centers, and the clinical diagnoses were supported by neurochemical dementia diagnostic (NDD) tools: CSF amyloidbeta peptides, Tau and phospho-Tau. sAPPalpha and sAPPbeta were measured with multiplexing method based on electrochemiluminescence. sAPPalpha and sAPPbeta CSF concentrations correlated with each other with very high correlation ratio (R=0.96, P

AB - In this report, we present the results of a multicenter study to test analytic and diagnostic performance of soluble forms of amyloid precursor proteins alpha and beta (sAPPalpha and sAPPbeta) in the cerebrospinal fluid (CSF) of patients with different forms of dementing conditions. CSF samples were collected from 188 patients with early dementia (mini-mental state examination>/=20 in majority of cases) and mild cognitive impairment (MCI) in 12 gerontopsychiatric centers, and the clinical diagnoses were supported by neurochemical dementia diagnostic (NDD) tools: CSF amyloidbeta peptides, Tau and phospho-Tau. sAPPalpha and sAPPbeta were measured with multiplexing method based on electrochemiluminescence. sAPPalpha and sAPPbeta CSF concentrations correlated with each other with very high correlation ratio (R=0.96, P

M3 - SCORING: Zeitschriftenaufsatz

JO - MOL PSYCHIATR

JF - MOL PSYCHIATR

SN - 1359-4184

ER -